• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

唐氏综合征和阿尔茨海默病患者大脑中突触体相关蛋白25水平降低。

Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down syndrome and Alzheimer's disease.

作者信息

Greber S, Lubec G, Cairns N, Fountoulakis M

机构信息

University of Vienna, Department of Pediatrics, Austria.

出版信息

Electrophoresis. 1999 Apr-May;20(4-5):928-34. doi: 10.1002/(SICI)1522-2683(19990101)20:4/5<928::AID-ELPS928>3.0.CO;2-Z.

DOI:10.1002/(SICI)1522-2683(19990101)20:4/5<928::AID-ELPS928>3.0.CO;2-Z
PMID:10344268
Abstract

Synaptosomal associated protein 25 kDa (snap-25) is a widely distributed membrane-associated protein in the brain, mainly localized in nerve terminals. In nerve terminals, snap-25 participates in docking and/or fusion of synaptic vesicles with the plasmalemma, a process essential for synaptic vesicle exocytosis. Recent work suggests a role in brain development, forming presynaptic sites by regulating axonal outgrowth and nerve growth-induced neurite elongation. In Down syndrome (DS) brain, it is abnormally developed from early life, and brain pathology becomes even more pronounced when Alzheimer's disease (AD) develops in the fourth decade. This information led us to examine snap-25 in the brain of patients with DS and AD. We studied snap-25 and glial fibrillary acidic protein (GFAP) brain levels in five individual brain areas of 9 aged patients with DS, 9 patients with AD and 9 controls, applying two-dimensional gel electrophoresis. Decreased snap-25 levels were found in the five brain regions of the patients with DS and AD. Increased expression levels of GFAP were found in the frontal, parietal, temporal and occipital cortex regions of the DS and AD patients. Decreased snap-25 protein levels in the brain of DS and AD may reflect impaired synaptogenesis or represent neuronal loss. Findings of increased GFAP, a marker for neuronal loss, along with data from literature would support the notion of decreased snap-25 secondary to neuronal decay in both neurodegenerative disorders.

摘要

突触体相关蛋白25千道尔顿(snap-25)是一种在大脑中广泛分布的膜相关蛋白,主要定位于神经末梢。在神经末梢中,snap-25参与突触小泡与质膜的对接和/或融合,这是突触小泡胞吐作用所必需的过程。最近的研究表明,它在大脑发育中发挥作用,通过调节轴突生长和神经生长诱导的神经突伸长来形成突触前位点。在唐氏综合征(DS)患者的大脑中,从早期就发育异常,当在第四个十年患阿尔茨海默病(AD)时,脑部病变会更加明显。这些信息促使我们研究DS和AD患者大脑中的snap-25。我们应用二维凝胶电泳技术,研究了9名老年DS患者、9名AD患者和9名对照者五个脑区中snap-25和胶质纤维酸性蛋白(GFAP)的脑水平。在DS和AD患者的五个脑区中发现snap-25水平降低。在DS和AD患者的额叶、顶叶、颞叶和枕叶皮质区域发现GFAP表达水平升高。DS和AD患者大脑中snap-25蛋白水平降低可能反映突触发生受损或代表神经元丢失。GFAP是神经元丢失的标志物,其升高的结果以及文献数据将支持这样的观点,即在这两种神经退行性疾病中,snap-25的降低继发于神经元衰退。

相似文献

1
Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down syndrome and Alzheimer's disease.唐氏综合征和阿尔茨海默病患者大脑中突触体相关蛋白25水平降低。
Electrophoresis. 1999 Apr-May;20(4-5):928-34. doi: 10.1002/(SICI)1522-2683(19990101)20:4/5<928::AID-ELPS928>3.0.CO;2-Z.
2
Synaptosomal proteins, beta-soluble N-ethylmaleimide-sensitive factor attachment protein (beta-SNAP), gamma-SNAP and synaptotagmin I in brain of patients with Down syndrome and Alzheimer's disease.唐氏综合征和阿尔茨海默病患者大脑中的突触体蛋白、β-可溶性N-乙基马来酰亚胺敏感因子附着蛋白(β-SNAP)、γ-SNAP和突触结合蛋白I
Dement Geriatr Cogn Disord. 2001 May-Jun;12(3):219-25. doi: 10.1159/000051261.
3
Neuroendocrine-specific protein C, a marker of neuronal differentiation, is reduced in brain of patients with Down syndrome and Alzheimer's disease.
Biochem Biophys Res Commun. 2000 Sep 16;276(1):329-34. doi: 10.1006/bbrc.2000.3464.
4
Changes of voltage-dependent anion-selective channel proteins VDAC1 and VDAC2 brain levels in patients with Alzheimer's disease and Down syndrome.阿尔茨海默病和唐氏综合征患者脑内电压依赖性阴离子选择性通道蛋白VDAC1和VDAC2水平的变化
Electrophoresis. 2001 Jan;22(1):172-9. doi: 10.1002/1522-2683(200101)22:1<172::AID-ELPS172>3.0.CO;2-P.
5
Differential involvement of synaptic vesicle and presynaptic plasma membrane proteins in Alzheimer's disease.突触小泡和突触前质膜蛋白在阿尔茨海默病中的差异参与情况。
Biochem Biophys Res Commun. 1997 Jul 18;236(2):239-42. doi: 10.1006/bbrc.1997.6940.
6
Reversal of amyloid beta toxicity in Alzheimer's disease model Tg2576 by intraventricular antiamyloid beta antibody.通过脑室内注射抗淀粉样β抗体逆转阿尔茨海默病模型Tg2576中的淀粉样β毒性。
J Neurosci Res. 2002 Jul 1;69(1):10-23. doi: 10.1002/jnr.10286.
7
Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease.在阿尔茨海默病患者海马提取物中,肽基精氨酸脱亚氨酶催化的瓜氨酸化蛋白异常蓄积。
J Neurosci Res. 2005 Apr 1;80(1):120-8. doi: 10.1002/jnr.20431.
8
Differential expression of molecular chaperones in brain of patients with Down syndrome.唐氏综合征患者大脑中分子伴侣的差异表达。
Electrophoresis. 2001 Apr;22(6):1233-41. doi: 10.1002/1522-2683()22:6<1233::AID-ELPS1233>3.0.CO;2-M.
9
Selective loss of synaptic proteins in Alzheimer's disease: evidence for an increased severity with APOE varepsilon4.阿尔茨海默病中突触蛋白的选择性缺失:携带APOEε4导致病情加重的证据
Neurochem Int. 2006 Dec;49(7):631-9. doi: 10.1016/j.neuint.2006.05.004. Epub 2006 Jun 30.
10
Aberrant expression of signaling-related proteins 14-3-3 gamma and RACK1 in fetal Down syndrome brain (trisomy 21).信号相关蛋白14-3-3γ和RACK1在胎儿唐氏综合征(21三体)大脑中的异常表达。
Electrophoresis. 2002 Jan;23(1):152-7. doi: 10.1002/1522-2683(200201)23:1<152::AID-ELPS152>3.0.CO;2-T.

引用本文的文献

1
Brain high-throughput multi-omics data reveal molecular heterogeneity in Alzheimer's disease.大脑高通量多组学数据揭示阿尔茨海默病的分子异质性。
PLoS Biol. 2024 Apr 30;22(4):e3002607. doi: 10.1371/journal.pbio.3002607. eCollection 2024 Apr.
2
Behavioral and Proteomic Studies Reveal Methylglyoxal Activate Pathways Associated with Alzheimer's Disease.行为学和蛋白质组学研究揭示甲基乙二醛激活与阿尔茨海默病相关的通路。
ACS Pharmacol Transl Sci. 2022 Dec 27;6(1):65-75. doi: 10.1021/acsptsci.2c00143. eCollection 2023 Jan 13.
3
miR-23a-3p and miR-181a-5p modulate SNAP-25 expression.
miR-23a-3p 和 miR-181a-5p 调节 SNAP-25 的表达。
PLoS One. 2023 Jan 17;18(1):e0279961. doi: 10.1371/journal.pone.0279961. eCollection 2023.
4
Reduced synaptic proteins and SNARE complexes in Down syndrome with Alzheimer's disease and the Dp16 mouse Down syndrome model: Impact of APP gene dose.唐氏综合征合并阿尔茨海默病患者及 Dp16 小鼠唐氏综合征模型中突触蛋白和 SNARE 复合物减少:APP 基因剂量的影响。
Alzheimers Dement. 2023 May;19(5):2095-2116. doi: 10.1002/alz.12835. Epub 2022 Nov 12.
5
WWOX inhibition by Zfra1-31 restores mitochondrial homeostasis and viability of neuronal cells exposed to high glucose.Zfra1-31 通过抑制 WWOX 恢复暴露于高葡萄糖的神经元细胞的线粒体动态平衡和活力。
Cell Mol Life Sci. 2022 Aug 19;79(9):487. doi: 10.1007/s00018-022-04508-7.
6
Dynamic Changes of Brain Cilia Transcriptomes across the Human Lifespan.人类一生中脑纤毛转录组的动态变化。
Int J Mol Sci. 2021 Sep 27;22(19):10387. doi: 10.3390/ijms221910387.
7
Cerebrospinal Fluid Biomarkers of Alzheimer's Disease: Current Evidence and Future Perspectives.阿尔茨海默病的脑脊液生物标志物:当前证据与未来展望
Brain Sci. 2021 Feb 10;11(2):215. doi: 10.3390/brainsci11020215.
8
Neuronal Porosome Complex: Secretory Machinery at the Nerve Terminal.神经元孔体复合体:神经末梢的分泌机制
Discoveries (Craiova). 2017 Jul 28;5(3):e77. doi: 10.15190/d.2017.7.
9
MicroRNA-153 impairs presynaptic plasticity by blocking vesicle release following chronic brain hypoperfusion.microRNA-153 通过阻断慢性脑低灌注后囊泡释放来损害突触前可塑性。
Cell Commun Signal. 2020 Apr 6;18(1):57. doi: 10.1186/s12964-020-00551-8.
10
BDNF-producing, amyloid β-specific CD4 T cells as targeted drug-delivery vehicles in Alzheimer's disease.产生脑源性神经营养因子的、针对淀粉样 β 的 CD4 T 细胞作为阿尔茨海默病的靶向药物递送载体。
EBioMedicine. 2019 May;43:424-434. doi: 10.1016/j.ebiom.2019.04.019. Epub 2019 May 11.